Do you think that quality would be adversely impacted if the growth in medical technology were to be constrained in the United States? If costs are reduced, and more people could have access, do you think that this is a reasonable trade-off?
i) How does the other country’s system work and how is it funded? Do the funding mechanisms work well in your view? (You might want to look at taxation rates.) Have there been implications to the country’s wider economy as a result of the cost of the system? Are they positive or negative?